Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of T-Cell Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of T-Cell Immunotherapymarket, defines the market attractiveness level of T-Cell Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of T-Cell Immunotherapy industry, describes the types of T-Cell Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global T-Cell Immunotherapy market and the development prospects and opportunities of T-Cell Immunotherapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global T-Cell Immunotherapy market in Chapter 13.
By Player:
Unum Therapeutics
Juno Therapeutics
Cellectis
Kite Pharma
Takara Bio
Altor Bioscience Corporation
Novartis
Adaptimmune
By Type:
CAR-T
TCR
TIL Therapies
By End-User:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 T-Cell Immunotherapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 T-Cell Immunotherapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 T-Cell Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 T-Cell Immunotherapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise T-Cell Immunotherapy Market Analysis and Outlook to 2022
-
7.1 Global T-Cell Immunotherapy Consumption (2017-2022)
-
7.2 United States T-Cell Immunotherapy Consumption (2017-2022)
-
7.3 Europe T-Cell Immunotherapy Consumption (2017-2022)
-
7.4 China T-Cell Immunotherapy Consumption (2017-2022)
-
7.5 Japan T-Cell Immunotherapy Consumption (2017-2022)
-
7.6 India T-Cell Immunotherapy Consumption (2017-2022)
-
7.7 South Korea T-Cell Immunotherapy Consumption (2017-2022)
8 Region and Country-wise T-Cell Immunotherapy Market Analysis and Outlook to 2028
-
8.1 Global T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.2 United States T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.3 Europe T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.4 China T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.5 Japan T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.6 India T-Cell Immunotherapy Consumption Forecast (2022-2028)
-
8.7 South Korea T-Cell Immunotherapy Consumption Forecast (2022-2028)
9 Global T-Cell Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global T-Cell Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CAR-T Consumption and Growth Rate (2017-2022)
-
9.1.2 Global TCR Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TIL Therapies Consumption and Growth Rate (2017-2022)
-
9.2 Global T-Cell Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Stomach Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Esophagus Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global T-Cell Immunotherapy Market Outlook by Types and Applications to 2028
-
10.1 Global T-Cell Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CAR-T Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global TCR Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TIL Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global T-Cell Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Esophagus Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global T-Cell Immunotherapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global T-Cell Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global T-Cell Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 T-Cell Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global T-Cell Immunotherapy Market Competitive Analysis
-
14.1 Unum Therapeutics
-
14.1.1 Unum Therapeutics Company Details
-
14.1.2 Unum Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Unum Therapeutics T-Cell Immunotherapy Product and Service
-
14.2 Juno Therapeutics
-
14.2.1 Juno Therapeutics Company Details
-
14.2.2 Juno Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Juno Therapeutics T-Cell Immunotherapy Product and Service
-
14.3 Cellectis
-
14.3.1 Cellectis Company Details
-
14.3.2 Cellectis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Cellectis T-Cell Immunotherapy Product and Service
-
14.4 Kite Pharma
-
14.4.1 Kite Pharma Company Details
-
14.4.2 Kite Pharma T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Kite Pharma T-Cell Immunotherapy Product and Service
-
14.5 Takara Bio
-
14.5.1 Takara Bio Company Details
-
14.5.2 Takara Bio T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takara Bio T-Cell Immunotherapy Product and Service
-
14.6 Altor Bioscience Corporation
-
14.6.1 Altor Bioscience Corporation Company Details
-
14.6.2 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Altor Bioscience Corporation T-Cell Immunotherapy Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis T-Cell Immunotherapy Product and Service
-
14.8 Adaptimmune
-
14.8.1 Adaptimmune Company Details
-
14.8.2 Adaptimmune T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Adaptimmune T-Cell Immunotherapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of T-Cell Immunotherapy
-
Figure T-Cell Immunotherapy Picture
-
Table Global T-Cell Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T-Cell Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T-Cell Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global T-Cell Immunotherapy Consumption by Country (2017-2022)
-
Figure United States T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure China T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CAR-T Consumption and Growth Rate (2017-2022)
-
Figure Global TCR Consumption and Growth Rate (2017-2022)
-
Figure Global TIL Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Stomach Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Esophagus Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CAR-T Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TCR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TIL Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Esophagus Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global T-Cell Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global T-Cell Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Unum Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Unum Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unum Therapeutics T-Cell Immunotherapy Product and Service
-
Table Juno Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Juno Therapeutics T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics T-Cell Immunotherapy Product and Service
-
Table Cellectis (Foundation Year, Company Profile and etc.)
-
Table Cellectis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellectis T-Cell Immunotherapy Product and Service
-
Table Kite Pharma (Foundation Year, Company Profile and etc.)
-
Table Kite Pharma T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kite Pharma T-Cell Immunotherapy Product and Service
-
Table Takara Bio (Foundation Year, Company Profile and etc.)
-
Table Takara Bio T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takara Bio T-Cell Immunotherapy Product and Service
-
Table Altor Bioscience Corporation (Foundation Year, Company Profile and etc.)
-
Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Altor Bioscience Corporation T-Cell Immunotherapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis T-Cell Immunotherapy Product and Service
-
Table Adaptimmune (Foundation Year, Company Profile and etc.)
-
Table Adaptimmune T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adaptimmune T-Cell Immunotherapy Product and Service
-
